H.U. Group Holdings, Inc.

Tokyo Stock Exchange 4544.T

H.U. Group Holdings, Inc. Current Liabilities for the year ending March 31, 2024: USD 423.31 M

H.U. Group Holdings, Inc. Current Liabilities is USD 423.31 M for the year ending March 31, 2024, a -12.63% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.

H.U. Group Holdings, Inc. Current Liabilities for the year ending March 31, 2023 was USD 484.52 M, a -16.64% change year over year.
H.U. Group Holdings, Inc. Current Liabilities for the year ending March 31, 2022 was USD 581.25 M, a 2.31% change year over year.
H.U. Group Holdings, Inc. Current Liabilities for the year ending March 31, 2021 was USD 568.15 M, a 10.49% change year over year.
H.U. Group Holdings, Inc. Current Liabilities for the year ending March 31, 2020 was USD 514.23 M, a 11.27% change year over year.

Key data

Date	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity	Long-Term Debt

Tokyo Stock Exchange: 4544.T

H.U. Group Holdings, Inc.

CEO	Mr. Shigekazu Takeuchi
IPO Date	Jan. 1, 2001
Location	Japan
Headquarters	Shinjuku Mitsui Building
Employees	5,295
Sector	Health Care
Industries Pharmaceuticals Biotechnology Hospitals & Clinics Medical Instruments

Description

H.U. Group Holdings, Inc., through its subsidiaries, provides laboratory testing products and services in Japan. The company offers lab testing and its related services to medical institutions; self-medication services; food, environment, and cosmetic testing services; and testing services through corporate health insurance associations. It also researches, develops, manufactures, and sells in vitro diagnostic devices, which includes the LUMIPULSE, an automatic chemiluminescent enzyme immunoassay system that offers reagents for infectious disease, cancer, and lifestyle disease to medical institutions and testing centers; and ESPRINE, a rapid diagnostics kit series for influenza, hepatitis B, and the novel coronavirus, as well as supplies ingredients for test drugs. In addition, the company provides support services related to hospital administration work, including aid for surgical procedures and endoscope room work, inspection and maintenance services for medical equipment, and in-hospital logistics management and transportation services; and rents and sells nursing-care equipment and supplies. Further, it offers home-visit nursing care services. The company was formerly known as Miraca Holdings Inc. and changed its name to H.U. Group Holdings, Inc. in July 2020. H.U. Group Holdings, Inc. was incorporated in 1950 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years